Compare Fiserv Inc. Common Stock (FISV) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fiserv Inc. Common Stock vs Novavax Inc — how do they compare? Fiserv Inc. Common Stock trades at $46.29 (market cap $24.81B), while Novavax Inc trades at $12.44 (market cap $2.11B). The key difference: Fiserv Inc. Common Stock is far larger — about 11.8× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Fiserv Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fiserv Inc. Common Stock for 0 Days and Novavax Inc for 59 Days on average.
| FISV | NVAX | |
|---|---|---|
Market Cap | $24.81B | $2.11B |
Volume | 4,091,234 | 8,376,831 |
Sector | Technology | Health |
52-Week High | $126.54 | $12.82 |
52-Week Low | $44.36 | $6.22 |
Typical Hold Time | 0 Days | 59 Days |
Enterprise Value | $52.60B | $1.69B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Novavax (NVAX) trades at $12.82, up 1.26% on the day, with a bullish technical signal and strong analyst support. Recent earnings beats and strategic pivots toward its Matrix-M adjuvant platform and partnerships, such as with Sanofi for COVID-19 vaccines, highlight operational progress. However, negative cash flows and a net loss in 2026 projections underscore financial volatility amid transitioning revenue streams.
The outlook balances near-term catalysts from vaccine approvals and partnership momentum against persistent cash burn and competitive pressures. Investors face opportunity in undervalued metrics like a low P/E of 3.14, but risks include execution hurdles and dependency on successful licensing deals to achieve sustainable profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fiserv Inc. Common Stock
Fiserv, Inc. is a global provider of payments and financial services technology, offering merchant acquiring, digital commerce, and financial solutions through its Merchant Solutions and Financial Solutions segments.
Read more on FISV →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
